Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 6Sanofi
02 2Dr. Reddy's Laboratories
03 2Actavis Inc
04 2Cheplapharm Arzneimittel Gmbh
05 2IVAX Pharmaceuticals Inc
06 2Interpharm
07 1Nesher Pharmaceuticals USA LLC
08 2ORIFARM GROUP AS
09 1Orspec Pharma
10 3Paranova Pharmaceuticals Ab
11 4Pfizer Inc
12 1Pharmaco
13 2Rising Pharmaceuticals Inc
14 2SUPERPHARM
15 2Sun Pharmaceutical Industries Limited
16 2Teva Pharmaceutical Industries
17 2Viatris
01 1CAP
02 1CAPSULE
03 3CAPSULE, EXTENDED RELEASE;ORAL
04 20CAPSULE;ORAL
05 1Capsule
06 1Depot tablet
07 1Disopyramide 100Mg 40 Combined Oral Use
08 1Disopyramide 250Mg 20 Joined' Oral Use
09 1Hard Capsule
10 6Tablet
11 1capsule
12 1Blank
01 1Authorized
02 15DISCN
03 7Deregistered
04 1Generic
05 1Prescription
06 8RX
07 5Blank
01 19DISOPYRAMIDE PHOSPHATE
02 1Dicorynan
03 1Durbis
04 7Durbis Retard
05 2NORPACE
06 2NORPACE CR
07 1RYTHMODAN
08 1Ritmodan
09 1Ritmodan Retard
10 1Rythmodan
11 1Rythmodan (Canada)
12 1Rythmodan 100 mg Capsules
01 2Australia
02 1Canada
03 2Italy
04 1Norway
05 1South Africa
06 1Spain
07 7Sweden
08 23USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Ritmodan
Dosage Form : Disopyramide 100Mg 40 Combined Oral Use
Dosage Strength : 40 cps 100 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DISOPYRAMIDE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1985-05-31
Application Number : 70173
Regulatory Info : RX
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Ritmodan Retard
Dosage Form : Disopyramide 250Mg 20 Joined' Oral Use
Dosage Strength : 20 CPR 250 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Norway
Brand Name : Durbis Retard
Dosage Form : Depot tablet
Dosage Strength : 250 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Durbis
Dosage Form : Capsule
Dosage Strength : 100mg
Packaging :
Approval Date : 12/05/1978
Application Number : 19780512000016
Regulatory Info : Deregistered
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Durbis Retard
Dosage Form : Tablet
Dosage Strength : 250mg
Packaging :
Approval Date : 16/10/1981
Application Number : 19811016000032
Regulatory Info : Deregistered
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Rythmodan 100 mg Capsules
Dosage Form : CAP
Dosage Strength : 100mg
Packaging : 100X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DISOPYRAMIDE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 1985-05-31
Application Number : 70173
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DISOPYRAMIDE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1986-02-02
Application Number : 70240
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DISOPYRAMIDE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 1986-02-02
Application Number : 70241
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DISOPYRAMIDE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1985-11-18
Application Number : 70186
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DISOPYRAMIDE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 1985-11-18
Application Number : 70187
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NORPACE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1982-01-01
Application Number : 17447
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NORPACE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 1982-01-01
Application Number : 17447
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NORPACE CR
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1982-07-20
Application Number : 18655
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NORPACE CR
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 1982-07-20
Application Number : 18655
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DISOPYRAMIDE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1985-02-22
Application Number : 70101
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DISOPYRAMIDE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 1985-02-22
Application Number : 70102
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DISOPYRAMIDE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1985-06-14
Application Number : 70138
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DISOPYRAMIDE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 1985-06-14
Application Number : 70139
Regulatory Info : DISCN
Registration Country : USA
